Sargramostim (GM-CSF) and lenalidomide in castration-resistant prostate cancer (CRPC): Results from a phase I-II clinical trial
Keywords: Castration-resistant prostate cancer (CRPC); Granulocyte-macrophage colony-stimulating factor (GM-CSF); Lenalidomide; Immunomodulation;